Crohn's disease: open trials in China

73 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
The Second Xiangya Hospital of Central South University, Changsha · Changzhou Second People's Hospital, Changzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Huizhou Central People's Hospital, Huizhou · The Second Affiliated Hospital of Soochow University, Suzhou · The Second Affiliated Hospital YuYing Childens Hospital of Wenzhou Medical university, Wenzhou · Zhongshan Hospital Affiliated to Xiamen University, Xiamen · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-11-04
NCT07483099
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Trial Treatment · Phase 2 · Eli Lilly and Company
The Second Xiangya Hospital of Central South University, Changsha · Changzhou Second People's Hospital, Changzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Huizhou Central People's Hospital, Huizhou · The Second Affiliated Hospital of Soochow University, Suzhou · The Second Affiliated Hospital YuYing Childens Hospital of Wenzhou Medical university, Wenzhou · Zhongshan Hospital Affiliated to Xiamen University, Xiamen · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Capital Center For Children's health Capital Medical University, Beijing · Changzhou No 2 Peoples Hospital, Changzhou · The Childrens Hospital, Zhejiang University School of Medicine, Hangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · Ruijin Hospital Shanghai Jiao Tong University, Shanghai · Shengjing Hospital Of China Medical University, Shenyang
Registry updated 2026-11-03
NCT07196722
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Capital Medical University, Beijing Friendship Hospital, Beijing · Xiangya Hospital Central South University, Changsha · The Second Xiangya Hospital of Central South University, Changsha · Changzhou No 2 Peoples Hospital, Changzhou · West China Hospital Si Chuan University, Chengdu · Chongqing General Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou · Affiliated Hospital of Hainan Medical University, Haikou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Anhui Medical University, Hefei · Huizhou Central People's Hospital, Huizhou · Jinhua Municipal Central Hospital, Jinhua · Lanzhou University Second Hospital, Lanzhou · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The Affiliated Hospital of Southwest Medical University, Luzhou · Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing · Zhongda Hospital Southeast University, Nanjing · The First Affiliated Hospital of Guangxi Medical University, Nanning · Ningbo Medical Center Lihuili Hospital, Ningbo · Huashan Hospital, Fudan University, Shanghai · Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University, Shanghai · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · Shenzhen Hospital of Southern Medical University, Shenzhen · Second Affiliated Hospital of Soochow University, Suzhou · The 2nd Affiliated Hospital & Yuying Children s Hospital Wenzhou Medical University, Wenzhou · The Central Hospital of Wuhan, Wuhan · Zhongshan Hospital Xiamen University, Xiamen · Northern Jiangsu Peoples hospital, Yangzhou · Zhuzhou Central Hospital, Zhuzhou · Affiliated Hospital of Zunyi Medical University, Zunyi
Registry updated 2026-11-03
NCT07310095
A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Trial Treatment · Phase 4 · Xian-Janssen Pharmaceutical Ltd.
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Anhui Medical University, Hefei · Ruijin hospital, Shanghai
Registry updated 2026-11-03
NCT07499232
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Changzhou No 2 Peoples Hospital, Changzhou · Chongqing General Hospital, Chongqing · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou · Zhongda Hospital Southeast University, Nanjing · Renmin Hospital of Wuhan University, Wuhan
Registry updated 2026-11-03
NCT07577843
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Peking University Third Hospital, Beijing · The Second Xiangya Hospital of Central South University, Changsha · Changzhou No 2 Peoples Hospital, Changzhou · West China Hospital Si Chuan University, Chengdu · Chongqing General Hospital, Chongqing · The First People's Hospital of Foshan, Foshan · Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital of Anhui Medical University, Hefei · Huai'an 1st Hospital, Huai'an · Lanzhou University Second Hospital, Lanzhou · Jiangsu Province Hospital, Nanjing · Ningbo Medical Center Lihuili Hospital, Ningbo · Ruijin Hospital Shanghai Jiao Tong University, Shanghai · Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · The Central Hospital of Wuhan, Wuhan · Wuxi People's Hospital, Wuxi · Zhongshan Hospital Xiamen University, Xiamen · Zhuzhou Central Hospital, Zhuzhou
Registry updated 2026-11-03
NCT05837897
A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease
Trial Treatment · Phase 3 · Takeda
Peking University Third Hospital, Beijing · Peking University First Hospital - Changqiao Campus, Beijing · The Second Xiangya Hospital of Central South University, Changsha · Changzhou No.2 People's Hospital - Yanling Campus, Changzhou · The First People's Hospital of Foshan, Foshan · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The First Affiliated Hospital, Sun Yat-sen University - Main, Guangzhou · Guangzhou First People's Hospital, Guangzhou · The Third Affiliated Hospital,Sun Yat-Sen University, Guangzhou · The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The 2nd Affliated Hospital of Harbin Medical University, Haerbin · The First Affiliated Hospital, Zhejiang University School of Medicine - Qingchun Campus - PPDS, Hangzhou · The Second Hospital of Anhui Medical University, Hefei · Huizhou Central People's Hospital, Huizhou · The First People's Hospital of Yunnan Province, Kunming · Lanzhou University Second Hospital, Lanzhou · The Second Affiliated Hospital of Nanchang University - Donghu Campus, Nanchang · Zhongda Hospital Affiliated to Southeast University, Nanjing · Nanyang First People's Hospital, Nanyang · The First Affiliated Hospital of Ningbo University - Fangqiao Campus, Ningbo · Qingyuan People's Hospital, Qingyuan · People's Hospital of Quzhou, Quzhou · Zhongshan Hospital,Fudan University, Shanghai · Shanghai East Hospital - Main, Shanghai · Shanghai Changhai Hospital, Shanghai · Shengjing Hospital of China Medical University (Nanhu Campus), Shenyang · The University of Hong Kong-Shenzhen Hospital, Shenzhen · The Second Hospital of Hebei Medical University - Main, Shijiazhuang · Changshu No.2 People's Hospital, Suzhou · Taizhou Hospital of Zhejiang Province - Main, Taizhou · The First People's Hospital of Wenling, Taizhou · Tianjin Medical University General Hospital, Tianjin · The 1st Affiliated Hospital of Wenzhou Medical University - Nanbaixiang Campus, Wenzhou · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Renmin Hospital of Wuhan University - Main Campus, Wuhan · Yijishan Hospital of Wannan Medical College, Wuhu · Xuzhou Central Hospital, Xuzhou · Yancheng NO.1 People's Hospital, Yancheng · Yantai Yuhuangding Hospital, Yantai · People's Hospital of Ningxia Hui Aotonomous Region, Yinchuan · Affiliated Hospital of Jiangsu University, Zhenjiang · The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai
Registry updated 2026-11-02
NCT06233461
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 2 · Takeda
The Second Xiangya Hospital of Central South University, Changsha · The Second People's Hospital of Changzhou, Changzhou · Chongqing General Hospital, Chongqing · Sun Yat-sen University - The Sixth Affiliated Hospital Guangdong Gastrointestinal Hospital, Guangzhou · Sun Yat-sen University (SYSU) - The First Affiliated Hospital, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Zhejiang University School of Medicine - Sir Run Run Shaw Hospital (SRRSH), Hangzhou · Huizhou First Hospital, Huizhou · Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai · Shanghai Pudong New District Zhoupu Hospital, Shanghai · Shanghai East Hospital, Shanghai · China Medical University (CMU) - Shengjing Hospital (The Second Affiliated Hospital) - Huaxiang Campus, Shenyang · The Second Affiliated Hospital of Soochow University, Suzhou · Wuhan University - Renmin Hospital (Hubei General Hospital), Wuhan · Zhongshan Hospital Xiamen University, Xiamen · The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang
Registry updated 2026-11-02
NCT06430801
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Peking University Third Hospital (Site 3910), Beijing · The Second Xiangya Hospital of Central South University-gastroenterology department (Site 3905), Changsha · West China Hospital, Sichuan University (Site 3929), Chengdu · Chongqing General Hospital (Site 3940), Chongqing · Dongguan People's Hospital (Site 3933), Dongguan · The First Affiliated Hospital Of Fujian Medical University (Site 3916), Fuzhou · The First Affiliated Hospital, Sun Yat-sen University (Site 3901), Guangzhou · The Sixth Affiliated Hospital of Sun Yat-sen University (Site 3907), Guangzhou · Sir Run Run Shaw Hospital of Zhejiang University School of Medicine-GI Medicine (Site 3902), Hangzhou · Anhui Provincial Hospital (Site 3922), Hefei · Huai'an First People's Hospital (Site 3948), Huaian · Huizhou Municipal Central Hospital (Site 3915), Huizhou · First Affiliated Hospital of Kunming Medical University (Site 3928), Kunming · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School (Site 3937), Nanjing · Zhongda Hospital Southeast University-Gastroenterology (Site 3911), Nanjing · Huashan Hospital of Fudan University (Site 3946), Shanghai · Shanghai East Hospital (Site 3914), Shanghai · Ruijin Hospital Shanghai Jiaotong University School of Medicine (Site 3931), Shanghai · Yuebei People's Hospital (Site 3912), Shaoguan · The University of Hong Kong-Shenzhen Hospital (Site 3930), Shenzhen · Shenzhen Hospital of Southern Medical University (Site 3932), Shenzhen · The Second Afilliated Hospital of Hebei Medical University (Site 3913), Shijiazhuang · Taihe Hospital (Site 3944), Shiyan · Suining Central Hospital (Site 3927), Suining · Taizhou Hospital of Zhejiang Province (Site 3936), Taizhou · Renmin Hospital of Wuhan University (Site 3921), Wuhan · Wuxi People's Hospital (Site 3925), Wuxi · Zhongshan Hospital Affiliated to Xiamen University (Site 3923), Xiamen · The First Affiliated hospital of Xiamen University (Site 3924), Xiamen · Tangdu Hospital of Fourth Military Medical University of Chinese People's Liberation Army (Site 3918), Xi'an · Yangzhou University Affiliated Hospital (Site 3947), Yangzhou · The Second Affiliated Hospital of Zhengzhou University (Site 3909), Zhengzhou · Affiliated Hospital of Jiangsu University (Site 3919), Zhenjiang · Changzhou No.2 People's Hospital (Site 3904), Zhenjiang
Registry updated 2026-11-02
NCT06958536
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Trial Treatment · Phase 2 · Sanofi
Changsha · Changsha · Changzhou · Guangzhou · Hangzhou · Nanchang · Shanghai · Shenyang
Registry updated 2026-11-02
NCT06819891
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Beijing Union Hospital, Beijing · Sichuan Provincial People's Hospital, Chengdu · First Affiliated Hospital Of Gannan Medical University, Ganzhou · Zhujiang Hospital, Southern Medical University, Guangzhou · Guangzhou First People's Hospital, Guangzhou · Hainan General Hospital, Haikou · Huai'an First People's Hospital, Huai'an · Huizhou First Hospital, Huizhou · Jinhua Municipal Central Hospital, Jinhua · The First Affilliated Hospital of Kunming Medical University, Kunming · The Second Affiliated Hospital of Nanchang University, Nanchang · Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai · Xinhua Hospital Affiliated To Shanghai Jiao tong University School of Medicine, Shanghai · Shengjing Hospital Of China Medical University, Shenyang · Hebei Medical University - The Second Hospital, Shijiazhuang · The Second Affiliated Hospital of Soochow University, Suzhou · The First Affiliated hospital of Xiamen University, Xiamen · The Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an · Affiliated Hospital of Jiangsu University, Zhenjiang
Registry updated 2026-10-26
NCT07184931
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Beijing · Beijing · Changsha · Changshu · Changzhou · Chengdu · Chengdu · Fuzhou · Guangzhou · Guangzhou · Guangzhou · Guangzhou · Hangzhou · Hangzhou · Hefei · Huizhou · Jinan · Jingzhou · Jinhua · Luzhou · Mianyang · Nanjing · Nanjing · Nanjing · Nanjing · Qingdao · Qingyuan · Shanghai · Shanghai · Shenzhen · Suzhou · Taizhou · Wenzhou · Wuhan · Wuhan · Wuxi · Xiamen · Yangzhou
Registry updated 2026-10-21
NCT07184944
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Sanofi
Guangzhou · Huizhou · Shanghai · Wuxi
Registry updated 2026-10-21
NCT05995353
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · AbbVie
Beijing Children's Hospital /ID# 256081, Beijing · Peking University Third Hospital /ID# 255876, Beijing · Hunan Children's Hospital /ID# 255610, Changsha · Guangzhou Medical University Affiliated Women and Children's Medical Center /ID# 255428, Guangzhou · The Sixth Affiliated Hospital of Sun Yat-sen University /ID# 270589, Guangzhou · Jiangxi Provincial Children's Hospital /ID# 255564, Nanchang · Children's Hospital of Shanghai /ID# 255531, Shanghai · Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 255688, Shanghai · Shengjing Hospital of China Medical University /ID# 255563, Shenyang · Henan Children's Hospital Zhengzhou Children's Hospital /ID# 255562, Zhengzhou
Registry updated 2026-10-20
NCT06819878
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Peking University Third Hospital, Beijing · The First Hospital of Jilin University, Changchun · Third Xiangya Hospital Centrel South University, Changsha · West China Hospital of Sichuan University, Chengdu · Chongqing General Hospital, Chongqing · The First Affiliated Hospital of Fujian Medical University, Fuzhou · The second Affiliated Hospital of Guangzhou Medical University, Guangzhou · The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University, Hangzhou · Zhejiang Province Traditional Chinese Medical Hospital, Hangzhou · The First Affiliated Hospital of Anhui Medical University, Hefei · Anhui Provincial Hospital, Hefei · Huizhou Central People's Hospital, Huizhou · The 1st Affiliated Hospital of Nanchang Unversity, Nanchang · The First Affiliate Hospital of Guangxi Medical University, Nanning · The First Affiliated Hospital of Ningbo University, Ningbo · Shanghai East Hospital, Shanghai · Peking University Shenzhen Hospital, Shenzhen · Taizhou Hospital of Zhejiang Province, Taizhou · The Central Hospital of Wuhan, Wuhan · Ren Min Hospital Affiliated Wu Han University, Wuhan · Wuxi People's Hospital, Wuxi · Zhongshan Hospital Xiamen University, Xiamen · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Zhuzhou Central Hospital, Zhuzhou
Registry updated 2026-10-16
NCT05906576
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Trial Treatment · Phase 4 · Taizhou Mabtech Pharmaceutical Co.,Ltd
Beijing Children's Hospital, Capital Medical University, Beijing
Registry updated 2026-09-30
NCT07758101
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease
Trial Treatment · Phase 1 · Guangdong Hengrui Pharmaceutical Co., Ltd
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-09-25
NCT07663526
Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
Trial Treatment · Phase 4 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Fuyang People's Hospital, Fuyang · Huai'an First People's Hospital, Huaian · Meihekou Central Hospital, Meihekou · Shanghai Jiao Tong University School of Medicine, Renji Hospital, Shanghai · Yancheng NO.1 People's Hospital, Yancheng · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Zhoukou Central Hospital, Zhoukou
Registry updated 2026-09-24
NCT07833332
Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease
Trial Treatment · Sixth Affiliated Hospital, Sun Yat-sen University
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
Registry updated 2026-09-22
NCT07824791
Prediction of Postoperative Recurrence in Crohn's Disease
Research · Sixth Affiliated Hospital, Sun Yat-sen University
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
Registry updated 2026-09-17
NCT07564505
A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease
Trial Treatment · Phase 4 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Women and Children's Medical Center, Guangzhou Medical University, Guangzhou
Registry updated 2026-09-10
NCT07504510
Exclusive Enteral Nutrition Therapy for Active and Complicated Crohn's Disease
Research · Sixth Affiliated Hospital, Sun Yat-sen University
The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou
Registry updated 2026-08-04
NCT05321745
Fecal Microbiota Transplantation in Pediatric Crohn's Disease
Trial Treatment · Biao Zou
Tongji Hospital, Wuhan
Registry updated 2026-07-10
NCT05321758
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
Trial Treatment · Tongji Hospital
Tongji Hospital, Wuhan
Registry updated 2026-07-10

All Crohn's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error